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Frequency of hepatitis B, C, and HIV
viruses among blood donors in Libya
H
epatitis B virus (HBV), hepatitis C virus (HCV),
and HIV infections represent a global public
health problem. Transmission of these viruses
occurs via blood and blood products transfusion and by
sexual contact (1). The infections caused by the three
viruses are not curable even with the latest available
treatments. Effective vaccine is available only for HBV.
In Libya, Zaied et al. (2), reported frequency rates of
0.4, 2.6, and 3% for anti-HIV antibodies, HBs-Ag,
and anti-HCV antibodies, respectively, which were also
reported by Habas et al. (3) and Abudher et al. (4).
However, the frequency of these viruses was not studied
in blood donors in Libya.
In the Central Hospital in Tripoli, Libya, all potential
blood donors were screened for detection of HBs-Ag,
anti-HCV, and HIV antibodies. The ELISA immunoas-
say method (VitrosEciQ, Orthodiagnostic) was used. Out
of 14,105 potential blood donors screened between
January 2005 and December 2008, there were 181, 98,
and 12 subjects found positive for HBs-Ag, anti-HCV,
and anti-HIV antibodies, respectively (Table 1). The
cumulative frequency of HBV, HCV, and HIV was 12.8,
6.9, and 0.9 per 1,000, respectively (Table 2).
Here, we are reporting that the frequency of the HBs-
Ag, anti-HCV, and anti-HIVamong healthy blood donors
is increasing. A previous study conducted in Tripoli in
randomly recruited subjects using a multistage sampling
technique reported that HBV and HCV infections were
detected in 2.2% and 1.2%, respectively (4). Another study
conducted during 2007 in Benghazi by Kutrani et al.
revealed that 51.2% were infected with HBV, 46.9% with
HCV, and 1.9% with hepatitis B and C (5).
In Libya, most of the blood donors are young men
(2040 years of age). It is known that this age group is
usually in the high-risk group for drug abuse, unprotected
sex, and other unsecure habits for the transmission of the
virus.
From this primary report, it can be concluded that
HBV, HCV, and HIV virus infection is a problem in
Libya. A community-based study should be planned for
targeting at risk and non-at risk subjects to investigate the
extent of this problem and its impact on the community
with an effort to develop preventive strategies.
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Table 1. The frequency of HBV, HCV, and HIV among
blood donors
Year Donors
HBV
positive (%)
HCV
positive (%)
HIV
positive (%)
2005 1,762 22 (1.2) 15 (8.5) 0 (0)
2006 4,169 51 (1.2) 20 (4.7) 2 (0.04)
2007 5,802 50 (8.6) 18 (3.1) 3 (0.05)
2008 2,372 58 (2.4) 45 (18.9) 7 (2.9)
Total 14,105 181 98 12
Table 2. The cumulative frequency of HBV, HCV, and HIV
among blood donors (per 1,000)
Cumulative frequency
Year Total screened HBV HCV HIV
20052006 5,931 12.3 5.9 0.3
20052007 11,733 10.5 4.5 0.4
20052008 14,105 12.8 6.9 0.9
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